3M (MMM) Stock Overview
Provides diversified technology services in the America, the Asia Pacific, Europe, the Middle East, Africa, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
MMM Community Fair Values
Create NarrativeSee what 292 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
3M Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$153.13 |
| 52 Week High | US$177.41 |
| 52 Week Low | US$139.34 |
| Beta | 1.09 |
| 1 Month Change | 7.46% |
| 3 Month Change | -3.38% |
| 1 Year Change | 4.60% |
| 3 Year Change | 56.29% |
| 5 Year Change | -24.84% |
| Change since IPO | 2,513.42% |
Recent News & Updates
Narrative Update • May 23
MMM: Margin Execution And Cash Returns Will Support Future Re Rating
Analysts have trimmed their 3M price target by about $1, reflecting slightly lower fair value estimates even as updated models factor in a reduced discount rate, modestly higher revenue growth, a small uptick in projected profit margins, and a somewhat lower future P/E assumption. Analyst Commentary Recent Street research around 3M and its healthcare spin-off Solventum gives you a mixed but generally constructive picture, with attention on how the separation could reshape both companies' earnings profiles and valuation frameworks.Seeking Alpha • May 15
3M: Iran Conflict And Inflationary Pressure Could Derail The Recovery
Summary 3M Company remains a hold as macro risks and litigation liabilities constrain its upside despite an otherwise solid business. MMM reported a solid Q1 2026 with 3.9% YoY adjusted sales growth, robust cash flow, and continued portfolio optimization, including a strategic fire and safety JV. Rising material costs, especially from oil-based inputs, and heightened macro uncertainty from Middle East conflicts threaten margins and valuation. Current valuation doesn't seem to imply a good enough margin of safety, while macro pressure and uncertainty justify a cautious stance. Read the full article on Seeking AlphaRecent updates
Narrative Update • May 23
MMM: Margin Execution And Cash Returns Will Support Future Re Rating
Analysts have trimmed their 3M price target by about $1, reflecting slightly lower fair value estimates even as updated models factor in a reduced discount rate, modestly higher revenue growth, a small uptick in projected profit margins, and a somewhat lower future P/E assumption. Analyst Commentary Recent Street research around 3M and its healthcare spin-off Solventum gives you a mixed but generally constructive picture, with attention on how the separation could reshape both companies' earnings profiles and valuation frameworks.Seeking Alpha • May 15
3M: Iran Conflict And Inflationary Pressure Could Derail The Recovery
Summary 3M Company remains a hold as macro risks and litigation liabilities constrain its upside despite an otherwise solid business. MMM reported a solid Q1 2026 with 3.9% YoY adjusted sales growth, robust cash flow, and continued portfolio optimization, including a strategic fire and safety JV. Rising material costs, especially from oil-based inputs, and heightened macro uncertainty from Middle East conflicts threaten margins and valuation. Current valuation doesn't seem to imply a good enough margin of safety, while macro pressure and uncertainty justify a cautious stance. Read the full article on Seeking Alpha
Narrative Update • May 03
MMM: Future Margin Execution And Buybacks Will Support Turnaround Prospects
Analysts have adjusted the 3M price target slightly lower to reflect a new fair value near $175, as recent target cuts from several firms and one smaller increase from Wells Fargo suggest a more cautious view on profit margins, while revenue growth assumptions and future P/E expectations remain steady to slightly higher. Analyst Commentary Recent Street research reflects a more mixed stance on 3M, with several firms trimming price targets and one lifting its target, all clustering around a fair value in the mid US$170s.Narrative Update • Apr 18
MMM: Execution On Margin Efficiency And Buybacks Will Support Future Re Rating
Analysts have trimmed their 3M fair value estimate by about $2 to $223.59, reflecting slightly lower profit margin assumptions that are only partly balanced by a modestly higher revenue growth outlook and a marginally richer future P/E multiple. Analyst Commentary Recent Street research on 3M reflects a mix of cautious revisions and selective optimism, with several firms adjusting price targets both higher and lower in response to updated assumptions.
New Narrative • Apr 11
3M Company (MMM): The "Industrial Rebirth" and the 2026 Operational Pivot
3M Company (MMM) closed the April 10, 2026, session at $150.32 USD on the NYSE, ending the week with a slight 0.12% daily decline. After years of being defined by sprawling litigation and a complex conglomerate structure, the central narrative for 2026 is "The Great Operational Reset" : Following the successful 2024 spinoff of its healthcare arm, Solventum (SOLV) , and the resolution of major PFAS and earplug legal tranches, 3M has emerged as a streamlined materials science specialist.Narrative Update • Apr 04
MMM: Operational Discipline And Legal Resolution Will Support Future Re Rating
Analysts have reduced the updated price target on 3M by about $1 to $225.94. This reflects a combination of recent target cuts and increases across firms, along with slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E.Narrative Update • Mar 21
MMM: Operational Progress And Legal Overhang Resolution Will Support Future Re Rating
The analyst price target for 3M has been adjusted by a few dollars, reflecting mixed but generally constructive updates from recent research. Some firms raised their targets by $2 to $5, while others trimmed theirs by $6 to $8, based on refreshed views of growth, profitability, and valuation assumptions.Narrative Update • Mar 06
MMM: Digital And Legal Progress Will Support Future Re Rating
The analyst price target for 3M has edged higher by about $1.50, as analysts weighed mixed target moves from major firms alongside slightly updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent Street research on 3M has been mixed, with some firms trimming their price targets while others raised theirs.Narrative Update • Feb 20
MMM: Digital Execution And Slightly Higher Fair Value Will Support Re Rating
The analyst price target for 3M has shifted slightly higher, with our fair value estimate moving from $223.00 to about $225.67 as analysts factor in updated growth and margin assumptions, along with mixed target revisions across major firms. Analyst Commentary Recent Street research on 3M shows a split view, with several bullish analysts lifting price targets and others trimming expectations or downgrading the stock.Narrative Update • Feb 05
MMM: Turnaround Prospects Will Be Tested By PFAS Litigation And Mixed Street Expectations
The analyst price target on 3M has been revised slightly higher to about $177 from $174, as analysts adjust their models for small changes in fair value, discount rate, revenue growth, profit margin, and future P/E assumptions following a mix of recent target increases and cuts across major firms. Analyst Commentary Recent Street research on 3M has been mixed, with several firms adjusting their price targets in both directions and one major downgrade.Narrative Update • Jan 22
MMM: New Digital Tools And Higher P E Multiple Will Support Re Rating
Analysts have nudged their valuation view on 3M higher, with the updated fair value estimate moving from $212 to $223 as they reassess the stock's longer term earnings power and apply a slightly richer future P/E multiple, despite mixed recent price target changes across the Street. Analyst Commentary Recent Street research on 3M has been mixed, with some firms trimming targets or ratings and others lifting their valuation marks.Narrative Update • Jan 07
MMM: Reset Expectations And New Products Will Support Higher Margins
Analysts have raised their fair value estimate for 3M to $212 from $187, citing expectations for higher profit margins, a slightly lower discount rate, and supportive Street research that highlights Q3 execution, new product traction, and reset expectations across multiple firms. Analyst Commentary Recent Street research around 3M clusters around a more constructive setup following Q3, with several bullish analysts revisiting their models on the back of reset expectations, new product traction, and updated legal and macro assumptions.
Narrative Update • Dec 24
MMM: PFAS Litigation Will Ultimately Cap Upside Despite Turnaround Progress
Analysts have raised their price target on 3M, lifting fair value by about $12 per share to roughly $126 as they grow more confident in the company’s improving organic growth, margin expansion, and turnaround initiatives, despite ongoing PFAS litigation risks. Analyst Commentary Recent Street research reflects a more balanced, but still risk aware, view on 3M as estimates reset and execution on the turnaround improves.Narrative Update • Dec 10
MMM: Turnaround Progress Will Face Ongoing PFAS Litigation And Portfolio Reshaping Risks
Our fair value estimate for 3M has been trimmed slightly to $174.25 from $174.94 as analysts balance higher price targets and improving expectations for new product driven growth and management's turnaround progress against persistent PFAS litigation risk. Analyst Commentary Street research remains divided on 3M, with recent notes highlighting improving execution and product driven growth, offset by continued concern around PFAS liabilities and mixed end market demand.Narrative Update • Nov 26
MMM: Shares Will Balance Turnaround Progress With Litigation and Asset Sale Uncertainty
Analysts have marginally raised their fair value estimate for 3M to $174.94, citing improved organic growth, ongoing new product introductions, and increased profit margin expectations following recent quarterly results. Analyst Commentary Recent analyst research has revealed a shifting perspective on 3M, as several experts adjust their outlooks based on the company’s latest earnings performance and ongoing strategic initiatives.Narrative Update • Nov 06
MMM: Shares Will Balance Turnaround Progress With Ongoing Litigation and Portfolio Changes
Analysts have raised their fair value estimate for 3M to $174.31 from $167.81. This change reflects improved organic growth prospects and progress on turnaround initiatives highlighted in recent research updates.Narrative Update • Oct 22
Analysts Divided on 3M as Fair Value Rises Amid New Initiatives and Persistent Risks
3M's fair value estimate has increased by $5.00 to $167.81 as analysts cite modest operating outperformance and positive momentum from new product initiatives, despite some lingering concerns. Analyst Commentary Recent updates from Street research highlight diverging analyst sentiment regarding 3M's valuation trajectory and execution on strategic initiatives.Narrative Update • Oct 08
New Product Launches And Efficiency Gains Will Boost Future Value
Narrative Update: 3M Analyst Price Target Revision Analysts have increased their price target for 3M to $162.81 from $161.63, citing improved full-year guidance prospects and renewed interest as a short-term buy idea. Analyst Commentary Recent commentary from Street research highlights both optimistic and cautious stances regarding 3M’s near-term prospects.Seeking Alpha • Mar 11
3M: Multiple Expansion Amidst Turnaround Success
Summary 3M has shown signs of a turnaround with a doubling stock price since October 2023, but operational top line growth remains modest, justifying a "hold" rating. The company expects modest organic revenue growth of 2-3% in 2025, driven by innovations and new product launches, but analysts are less optimistic. Current valuation is high with a forward P/E ratio above the five-year median, limiting upside potential amid risks like trade disputes and economic slowdowns. Read the full article on Seeking AlphaSeeking Alpha • Feb 07
3M: More Upside Ahead - But Wait For A Moderate Retracement
Summary MMM's reversal is already here, thanks to the SOLV divestiture bringing forth a more focused portfolio and healthier balance sheet. This is on top of the resolution of its legal headwinds, as management also pursues insurance recovery and $340M already completed. The management has driven new growth opportunities through its legacy businesses and new product launches as well, despite certain market softness. These reasons are likely why the market has upgraded MMM's valuations and the investors have defended the stock's uptrend support line thus far. With double digit capital appreciation prospects, we are reiterating our Buy rating here with one caveat. We shall further discuss. Read the full article on Seeking AlphaSeeking Alpha • Jan 23
3M Is Structurally Shifting For Durable Growth
Summary 3M's focus on innovation and operational improvements under CEO Bill Brown may lead to significant top-line growth and margin expansion. Management is aiming to enhance supply chain efficiencies and increasing production launches while improving the firm's on-time, in-full deliveries. 3M has a substantial amount of inventory that may be worked down in the coming quarters, potentially acting as a tailwind for free cash flow generation in the coming years. Read the full article on Seeking AlphaSeeking Alpha • Jan 06
Downgrading 3M Due To Persistent Litigation Risks And Stagnant Sales Growth
Summary I am downgrading 3M from hold to sell due to slow revenue growth, ongoing litigation risks, and inflated stock valuation despite recent gains. Revenue growth is expected to underpace inflation, driven by product line adjustments, declining European demand, and the healthcare spin-off. Despite settling some litigations, 3M faces significant pending lawsuits, posing substantial financial risks. Shares appear expensive when accounting for slow growth and litigation risks, with a fair value estimate of $86 per share, 34% below current trading. Read the full article on Seeking AlphaSeeking Alpha • Dec 30
One Of JPMorgan's Value Picks For 2025, 3M Could Have A Bright Year Ahead
Summary JPMorgan highlights 3M Company as a key investment idea for 2025, despite ongoing legal challenges and growth issues, leading to my Hold rating. 3M's diverse operations span Safety & Industrial, Transportation & Electronics, Consumer, and Healthcare, with a strong focus on innovation and high-margin products. The company reported 1% organic growth and an 18% rise in adjusted EPS for Q3 2024, showcasing operational efficiency and cost management. With a healthy 23% margin and $1.5 billion free cash flow, MMM balances rewarding shareholders with investing in growth initiatives. Read the full article on Seeking AlphaSeeking Alpha • Nov 25
3M: Seems A Bit Too Expensive Considering The Slow Growth
Summary Earlier this year, CEO William Brown said 3M's products are aging. Now and in the near future, it seems like the company is focussing on new products and research. It seems like the uncertainty-creating lawsuits are now largely settled, but the costs will weigh on the company for several years to come. Nevertheless, 3M has a strong financial position and rewards its shareholders with dividends and buybacks, but I'm waiting because I believe it is slightly too expensive. Read the full article on Seeking AlphaSeeking Alpha • Oct 24
3M: Multiple Expansion But Problems Linger
Summary 3M's Q3 earnings beat expectations with $1.98/share, driven by margin expansion from restructuring, despite lackluster 1.5% organic revenue growth. The company repurchased $700 million in stock, raising concerns about prioritizing buybacks over addressing future PFAS liabilities and debt reduction. 3M faces significant PFAS-related lawsuits, posing potential billions in liabilities, making stock buybacks questionable given the financial risks. Despite a 30% stock appreciation, driven by multiple expansion, revenue growth remains below inflation, and future liabilities pose significant downside risks. Read the full article on Seeking AlphaSeeking Alpha • Oct 01
3M's Transformation Uncertain: A Wait-And-See Approach
Summary 3M is undergoing a challenging transformation with stagnant revenue, rising debt, and significant legal risks from PFAS litigation, leading to a 32% stock price decline since 2021. Despite a strong global product portfolio and solid cash flow, current free cash flow is insufficient to cover dividends and share buybacks, raising concerns. New CEO William Brown brings valuable experience but skepticism remains about his ability to drive a radical transformation, given past performance and substantial PFAS liabilities. I estimate 3M's value at $125 per share, slightly lower than its current price, and recommend holding due to unclear recovery path. Read the full article on Seeking AlphaSeeking Alpha • Aug 30
3M: A Bright Future, But Shares Hit Fair Value Amid Strong Momentum (Rating Downgrade)
Summary 3M's Q2 earnings report was exceptionally strong, leading to a 23% stock surge and a 46% YTD performance, the best in the DJIA. Despite robust technical momentum and a rising trend, 3M's stock is close to fair value, warranting a hold rating for now. Key risks include potential macroeconomic slowdowns, a strong US dollar, and an untested new CEO, but future EPS growth looks promising. With a decent 2.11% dividend yield and potential for payout boosts, 3M's long-term growth trajectory appears stable post-Solventum spinoff. I outline key price levels to monitor on chart, as momentum remains very impressive. Read the full article on Seeking Alpha
New Narrative • Aug 20
Restructuring And Critical Shifts Poised To Transform Operational Efficiencies And Net Margins
Restructuring and focusing on high-growth areas like auto electrification and climate tech are set to drive margin expansions and top-line growth.Seeking Alpha • Aug 01
3M's New CEO Spills The Beans
Summary 3M's core was tired before the new CEO, Bill Brown, took over. In the recent earnings call, he spilled the beans on this fact. He is displaying leadership and didn't mention AI one time, yet turning around the culture in a company like 3M is no small task. Investors who purchased 3M early this year and sold the Solventum shares have experienced gains exceeding 60%. My target price is $86. The market may move it to more like $110. Read the full article on Seeking AlphaShareholder Returns
| MMM | US Industrials | US Market | |
|---|---|---|---|
| 7D | 0.5% | 2.9% | 1.6% |
| 1Y | 4.6% | 3.5% | 28.2% |
Return vs Industry: MMM exceeded the US Industrials industry which returned 3.5% over the past year.
Return vs Market: MMM underperformed the US Market which returned 28.2% over the past year.
Price Volatility
| MMM volatility | |
|---|---|
| MMM Average Weekly Movement | 3.8% |
| Industrials Industry Average Movement | 3.8% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MMM has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: MMM's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1902 | 60,500 | Bill Brown | www.3m.com |
3M Company provides diversified technology services in the America, the Asia Pacific, Europe, the Middle East, Africa, and internationally. It operates through three segments: Safety and Industrial, Transportation and Electronics, and Consumer. The Safety and Industrial segment provides industrial abrasives and finishing for metalworking applications; autobody repair solutions; industrial specialty products, such as personal hygiene products, masking, and packaging materials; electrical products and materials for construction and maintenance, power distribution, and electrical original equipment manufacturers; structural adhesives and tapes; respiratory, hearing, eye, and fall protection solutions; and natural and color-coated mineral granules for shingles.
3M Company Fundamentals Summary
| MMM fundamental statistics | |
|---|---|
| Market cap | US$79.87b |
| Earnings (TTM) | US$2.79b |
| Revenue (TTM) | US$25.02b |
28.7x
P/E Ratio3.2x
P/S RatioIs MMM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MMM income statement (TTM) | |
|---|---|
| Revenue | US$25.02b |
| Cost of Revenue | US$15.09b |
| Gross Profit | US$9.94b |
| Other Expenses | US$7.15b |
| Earnings | US$2.79b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.34 |
| Gross Margin | 39.71% |
| Net Profit Margin | 11.14% |
| Debt/Equity Ratio | 379.2% |
How did MMM perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yield57%
Payout RatioDoes MMM pay a reliable dividends?
See MMM dividend history and benchmarks| 3M dividend dates | |
|---|---|
| Ex Dividend Date | May 22 2026 |
| Dividend Pay Date | Jun 12 2026 |
| Days until Ex dividend | 10 days |
| Days until Dividend pay date | 11 days |
Does MMM pay a reliable dividends?
See MMM dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/01 04:11 |
| End of Day Share Price | 2026/05/29 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
3M Company is covered by 30 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Eade | Argus Research Company |
| Julian Mitchell | Barclays |
| Robert Cornell | Barclays |